Loading
Fungal Infections and Studies / Actinomycetales Infections and Treatment / Infectious Diseases and Mycology · Journal article
Lupus · August 16, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is a single case report of disseminated Nocardia pseudobrasiliensis infection successfully treated in a juvenile lupus patient on immunosuppressive therapy. The case illustrates a rare opportunistic infection and its clinical management but provides only descriptive evidence insufficient to guide practice.
Single case report. One juvenile patient with systemic lupus erythematosus on immunosuppressive therapy who developed disseminated nocardiosis following steroid dose escalation after a minor organ flare. Intervention: Intravenous meropenem, intravenous amikacin, and oral cotrimoxazole for 6 weeks; followed by planned oral cotrimoxazole monotherapy for 1 year.
Disseminated nocardiosis presented as necrotizing pneumonia, subcutaneous nodules, and CNS lesion in right parietal lobe following steroid escalation Intravenous meropenem, amikacin, and oral cotrimoxazole for 6 weeks led to pneumonia resolution and partial resolution of cutaneous and CNS lesions Patient planned for extended oral cotrimoxazole therapy for 1 year due to immunosuppression and disseminated disease
No systematic assessment of treatment toxicity or adverse effects reported
This case alerts clinicians to the possibility of disseminated nocardiosis as an opportunistic infection in immunosuppressed lupus patients, particularly following steroid escalation. It describes a successful treatment regimen but provides no evidence base for generalizing outcomes or changing practice.
Single case report describing management and clinical course of an uncommon opportunistic infection in a juvenile lupus patient; provides no comparative data or outcome metrics beyond descriptive resolution.
As stated by the source record.
Quoted from the source exactly as published.
This case alerts clinicians to the possibility of disseminated nocardiosis as an opportunistic infection in immunosuppressed lupus patients, particularly following steroid escalation. It describes a successful treatment regimen but provides no evidence base for generalizing outcomes or changing practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
Nocardiosis is an uncommon infection that presents as a chronic, debilitating illness with radiographic manifestations simulating lung cancer or tuberculosis. Immunocompromised hosts may develop a fulminant disease resembling acute bacterial pneumonia or disseminated disease. We report a case of a juvenile lupus who developed disseminated Nocardia pseudobrasilienisis infection in form of necrotizing pneumonia, subcutaneous nodules and central nervous system (CNS) lesion in the right parietal lobe, following inadvertent hiking of steroids after a minor organ flare. This case was successfully treated with intravenous meropenem, amikacin, and oral cotrimoxazole therapy for 6 weeks which lead to resolution of pneumonia, and partial resolution of of the cutaneous and CNS lesion. As the patient was immunosuppressed, and had disseminated nocardiosis, we planned to put her on oral cotrimoxazole for the next 1 year.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.